Scyllitol

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameScyllitol
Drug Alias NameQuercinitol้ฒจ่‚Œ้†‡้’่Ÿน่‚Œ้†‡ScylloinositolScyllo-Inositol +[8]ย 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta amyloid A4 protein inhibitors
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsBipolar DisorderDown SyndromeAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBulgariaCanada +[10]ย 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTransition Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOpko Health Inc
Active IndicationsN/A
Inactive IndicationsBipolar DisorderDown SyndromeAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksWikipedia